Literature DB >> 20657745

MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers.

Lourdes García-Fragoso1, Inés García-García, Gloria Leavitt, Jessicca Renta, Miguel A Ayala, Carmen L Cadilla.   

Abstract

Congenital heart defects (CHD) are among the most common birth defects. There is evidence suggesting that polymorphisms in folate metabolism could alter susceptibility to CHD. The MTHFR 677TT genotype has been associated with the development of structural congenital heart malformations. The objective of this study was to identify common polymorphisms in the MTHFR gene in children with isolated CHD and their mothers. The DNA analysis for the C677T and A1298C mutations was performed. The study group included 27 mothers, 27 children with CHD, and 220 controls. The prevalence of the TT polymorphism was higher in mothers (22%) than in controls (10%). Compound heterozygosity for both polymorphisms was 3.7 times more common in children with CHD than in the newborn controls. Mothers of children with CHD were more likely to be compound heterozygotes. The higher prevalence of C677T polymorphisms in mothers of children with CHD and of compound heterozygosity for both polymorphisms suggests the possible role of folic acid in the prevention of CHD. Due to the relation of this enzyme to folate metabolism, current folate recommendations for women in childbearing age in Puerto Rico to reduce neural tube defects may need to be extended to the prevention of CHD.

Entities:  

Year:  2010        PMID: 20657745      PMCID: PMC2908276     

Source DB:  PubMed          Journal:  Int J Genet Mol Biol        ISSN: 2006-9863


  22 in total

1.  Noninherited risk factors and congenital cardiovascular defects: current knowledge.

Authors: 
Journal:  Pediatrics       Date:  2007-08       Impact factor: 7.124

2.  Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Authors:  Pedro J Santiago Borrero; Yolanda Rodríguez-Pérez; Jessicca Y Renta; Natalio J Izquierdo; Laura Del Fierro; Daniel Muñoz; Norma López Molina; Sonia Ramírez; Glorivee Pagán-Mercado; Idith Ortíz; Enid Rivera-Caragol; Richard A Spritz; Carmen L Cadilla
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study.

Authors:  L D Botto; M J Khoury; J Mulinare; J D Erickson
Journal:  Pediatrics       Date:  1996-11       Impact factor: 7.124

4.  Occurrence of congenital heart defects in relation to maternal mulitivitamin use.

Authors:  L D Botto; J Mulinare; J D Erickson
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

5.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis.

Authors:  Anna Verkleij-Hagoort; Johannes Bliek; Fakhredin Sayed-Tabatabaei; Nicolette Ursem; Eric Steegers; Régine Steegers-Theunissen
Journal:  Am J Med Genet A       Date:  2007-05-01       Impact factor: 2.802

7.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring.

Authors:  G M Shaw; C D O'Malley; C R Wasserman; M M Tolarova; E J Lammer
Journal:  Am J Med Genet       Date:  1995-12-04

Review 9.  Folic acid for the prevention of congenital anomalies.

Authors:  J Hall; F Solehdin
Journal:  Eur J Pediatr       Date:  1998-06       Impact factor: 3.183

10.  Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

Authors:  Raluca Ionescu-Ittu; Ariane J Marelli; Andrew S Mackie; Louise Pilote
Journal:  BMJ       Date:  2009-05-12
View more
  17 in total

1.  Polymorphism 677C → T MTHFR gene in Mexican mothers of children with complex congenital heart disease.

Authors:  Norma A Balderrábano-Saucedo; Rocio Sánchez-Urbina; José A Sierra-Ramírez; Normand García-Hernández; Adriana Sánchez-Boiso; Miguel Klunder-Klunder; Diego Arenas-Aranda; Gabriela Bravo-Hernández; Penelope Noriega-Zapata; Alfredo Vizcaíno-Alarcón
Journal:  Pediatr Cardiol       Date:  2012-06-04       Impact factor: 1.655

Review 2.  Association between MTHFR C677T polymorphism and congenital heart disease. A family-based meta-analysis.

Authors:  Z Li; Y Jun; R Zhong-Bao; L Jie; L Jian-Ming
Journal:  Herz       Date:  2014-09-27       Impact factor: 1.443

3.  Whole genome sequencing identifies ANXA3 and MTHFR mutations in a large family with an unknown equinus deformity associated genetic disorder.

Authors:  Zhiqun Zhang; Zhuqing Kong; Miao Zhu; Wenxiang Lu; Lei Ni; Yunfei Bai; Yue Lou
Journal:  Mol Biol Rep       Date:  2016-07-30       Impact factor: 2.316

Review 4.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

Review 5.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

6.  The A1298C Methylenetetrahydrofolate Reductase Gene Variant as a Susceptibility Gene for Non-Syndromic Conotruncal Heart Defects in an Indian Population.

Authors:  Teena Koshy; Vettriselvi Venkatesan; Venkatachalam Perumal; Sridevi Hegde; Solomon Franklin Durairaj Paul
Journal:  Pediatr Cardiol       Date:  2015-05-17       Impact factor: 1.655

7.  Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy.

Authors:  Francisco J Jiménez-Ramírez; Liza M Castro; Clarymar Ortiz; Jennifer Concepción; Jessicca Y Renta; Raúl H Morales-Borges; Jorge R Miranda-Massari; Jorge Duconge
Journal:  Drug Metab Pers Ther       Date:  2017-03-01

8.  The association of the MTHFR c.1625A>C genetic variant with the risk of congenital heart diseases in the Chinese.

Authors:  Yuting Wang; Lei Sun; Weina Du; Shuang Song; Shuo Wang; Weiju Jiang; Tianchu Huang; Hui Li
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

Review 9.  Pharmacogenetics of healthy volunteers in Puerto Rico.

Authors:  Karla Claudio-Campos; Carmelo Orengo-Mercado; Jessicca Y Renta; Muriel Peguero; Ricardo García; Gabriel Hernández; Susan Corey; Carmen L Cadilla; Jorge Duconge
Journal:  Drug Metab Pers Ther       Date:  2015-12

10.  Maternal Hypertension-Related Genotypes and Congenital Heart Defects.

Authors:  Yunping Lei; Katherine L Ludorf; Xiao Yu; Renata H Benjamin; Xue Gu; Ying Lin; Richard H Finnell; Laura E Mitchell; Fadi I Musfee; Sadia Malik; Mark A Canfield; Alanna C Morrison; Charlotte A Hobbs; Alissa R Van Zutphen; Sarah Fisher; A J Agopian
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.